2025 annual financial data
Scinai Immunotherapeutics 2025 Operating margin
Direct answer
Operating margin was -575.29%.
Operating income was -7,542,000 USD and net income was -8,307,000 USD.
Operating cash flow was -6,031,000 USD.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,311,000 USD
- Operating income
- -7,542,000 USD
- Net income
- -8,307,000 USD
- Operating cash flow
- -6,031,000 USD